Founded in 2021, the Hong Kong-based Agilis Robotics specializes in developing innovative surgical robots designed to operate ...

Transforming Bladder Cancer Treatment with Robotic Innovation The gold standard for early-stage bladder cancer treatment is ...

Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain ...

The following is a summary of “Need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer ...

From review of the currently available trial evidence, several clinical recommendations for bladder tumor management become apparent. Transurethral resection should be done, but this procedure is ...

Bladder tumors, though less discussed than other forms of cancer, are a significant health concern. They arise from the lining of the urinary tract, known as th ...

LUGPA annual meeting, Gautam Jayram, MD, reviewed important developments therapeutics and diagnosis and staging.

Bladder cancer ranks as the 10th most commonly diagnosed cancer globally, affecting both men and women. Approximately 75% of patients are initially diagnosed with non-muscle invasive bladder cancer ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

Primary Signet Ring Cell Carcinoma (SRCC) of the bladder accounts for only 1%‒4% of all bladder malignancies ... Inclusion criteria were as follows: (1) Pathological examination after biopsy by ...

We present retrospective data of patients with nonmuscle invasive bladder cancer (NMIBC) who underwent restaging transurethral resection of bladder tumor (Re-TURBT) at a tertiary care center. Records ...

2024 Rationale of restaging transurethral resection of bladder tumor in patients with nonmuscle invasive bladder cancer in the current era. December 2, 2024 Use of Multiparametric and Biparametric ...